Precision Medicine for Cancer-Associated Thrombosis: The Role of Biomarkers
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 69
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer-associated thrombosis (CAT) is a significant cause of morbidity and mortality in cancer patients, often complicating treatment and impacting overall survival. While conventional risk assessment models exist, they often lack the precision needed to accurately identify individuals at highest risk. This Special Issue delves into the crucial role of precision medicine in refining our understanding and prediction of CAT, offering a path towards personalized prevention and treatment strategies.
This Special Issue aims to explore the latest advancements in biomarker research related to CAT. We invite submissions that focus on the discovery, validation, and clinical application of biomarkers for risk stratification, early diagnosis, and prediction of treatment response in CAT. We welcome original research articles, reviews, and meta-analyses that address the challenges and opportunities of implementing biomarker-guided precision medicine approaches to improve outcomes for cancer patients at risk of thrombosis.
Dr. Darko Antic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- precision medicine
- cancer-associated thrombosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
